Development of a Cascade of Care for responding to the opioid epidemic
- PMID: 30675818
- PMCID: PMC6404749
- DOI: 10.1080/00952990.2018.1546862
Development of a Cascade of Care for responding to the opioid epidemic
Abstract
Amid worsening opioid overdose death rates, the nation continues to face a persistent addiction treatment gap limiting access to quality care for opioid use disorder (OUD). Three FDA-approved medications (methadone, buprenorphine, and extended-release naltrexone) have high quality evidence demonstrating reductions in drug use and overdose events, but most individuals with OUD do not receive them. The development of a unified public health framework, such as a Cascade of Care, could improve system level practice and treatment outcomes. In response to feedback from many stakeholders over the past year, we have expanded upon the OUD treatment cascade, first published in 2017, with additional attention to prevention stages and both individual-level and population-based services to better inform efforts at the state and federal level. The proposed cascade framework has attracted considerable interest from federal agencies including the Centers for Disease Control and Prevention (CDC) and National Institute on Drug Abuse (NIDA) along with policy-makers nationwide. We have reviewed recent literature and evidence-based interventions related to prevention, identification, and treatment of individuals with OUD and modeled updated figures from the 2016 National Survey on Drug Use and Health. Many currently employed interventions (prescriber guidelines, prescription monitoring programs, naloxone rescue) address prevention of OUD or downstream complications but not treatment of the underlying disorder itself. An OUD Cascade of Care framework could help structure local and national efforts to combat the opioid epidemic by identifying key targets, interventions, and quality indicators across populations and settings to achieve these ends. Improved data collection and reporting methodology will be imperative.
Keywords: Health Services Research; Medication Assisted Treatment; Medications for Opioid Use Disorder; OUD Cascade of Care; Opioid Use Disorder.
Conflict of interest statement
Conflicts of Interest: Dr. Nunes received medication or software for research studies from Alkermes and Reckitt-Benckiser. Dr. Bisaga received medication, extended-release naltrexone, for NIH funded research studies from Alkermes.
Figures
References
-
- Centers for Disease Control and Prevention. National Vital Statistics System. Provisional counts of drug overdose deaths as of 9/5/2018. National Center for Health Statistics, Centers for Disease Control and Prevention, 2018.
-
- Ali MK, Bullard KM, Gregg EW, et al. A Cascade of Care for Diabetes in the United States: Visualizing the Gaps. Annals Int Med. 2014;161(10):681–689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous